{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:25:51Z","timestamp":1777922751807,"version":"3.51.4"},"reference-count":41,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Microbial Drug Resistance"],"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:p>\n                    Many species of nontuberculous mycobacteria (NTM) have long been identified as important causes of human disease, the incidence of which is rising. Several reports have suggested increasing trend of both\n                    <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                    resistance to available treatment regimes. The aim of this study was to evaluate antibiotic susceptibility of clinically relevant NTM isolates using standard microbroth dilution test. Antimicrobial susceptibility testing was performed following National Committee for Clinical Laboratory Standards methods for NTM isolates, including 85\n                    <jats:italic toggle=\"yes\">Mycobacterium fortuitum<\/jats:italic>\n                    , 39\n                    <jats:italic toggle=\"yes\">Mycobacterium chelonae<\/jats:italic>\n                    , and 30\n                    <jats:italic toggle=\"yes\">Mycobacterium abscessus<\/jats:italic>\n                    subsp.\n                    <jats:italic toggle=\"yes\">abscessus<\/jats:italic>\n                    as rapidly growing mycobacteria and 48\n                    <jats:italic toggle=\"yes\">Mycobacterium simiae<\/jats:italic>\n                    and 40\n                    <jats:italic toggle=\"yes\">Mycobacterium kansasii<\/jats:italic>\n                    as slowly growing mycobacteria. All isolates were recovered from various types of clinical samples and identified by multilocus sequence analysis. Trimethoprim\u2013sulfamethoxazole (TMP-SMZ), amikacin, tobramycin, clarithromycin, moxifloxacin, linezolid, and imipenem showed better activity against\n                    <jats:italic toggle=\"yes\">M. fortuitum<\/jats:italic>\n                    rather than meropenem, ciprofloxacin, cefoxitin, and doxycycline. Amikacin was active against 93% of\n                    <jats:italic toggle=\"yes\">M. abscessus<\/jats:italic>\n                    subsp.\n                    <jats:italic toggle=\"yes\">abscessus.<\/jats:italic>\n                    Linezolid, clarithromycin, cefoxitin, ciprofloxacin, imipenem, moxifloxacin, tobramycin, TMP-SMZ, doxycycline, and meropenem showed some activities on\n                    <jats:italic toggle=\"yes\">M. abscessus<\/jats:italic>\n                    subsp.\n                    <jats:italic toggle=\"yes\">abscessus<\/jats:italic>\n                    as well. The majority of\n                    <jats:italic toggle=\"yes\">M. abscessus<\/jats:italic>\n                    subsp.\n                    <jats:italic toggle=\"yes\">abscessus<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">M. chelonae<\/jats:italic>\n                    strains were multidrug resistant. Among the 40 isolates of\n                    <jats:italic toggle=\"yes\">M. kansasii<\/jats:italic>\n                    , all were susceptible to ethambutol, isoniazid, clarithromycin, moxifloxacin, and linezolid. These isolates were also resistant to doxycycline and 50% were resistant to rifampicin and ciprofloxacin.\n                    <jats:italic toggle=\"yes\">M. simiae<\/jats:italic>\n                    was resistant to clarithromycin, doxycycline, isoniazid, and TMP-SMZ, and the majority of isolates showed high levels of resistance to linezolid, ethambutol, ciprofloxacin, streptomycin, and rifampicin. The majority of\n                    <jats:italic toggle=\"yes\">M. simiae<\/jats:italic>\n                    isolates were multidrug resistant. Our data confirm the need for performing of standard susceptibility testing of any clinically important NTM isolate.\n                  <\/jats:p>","DOI":"10.1089\/mdr.2015.0134","type":"journal-article","created":{"date-parts":[[2015,10,15]],"date-time":"2015-10-15T15:16:14Z","timestamp":1444922174000},"page":"172-178","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":39,"title":["<i>In Vitro<\/i>\n                    Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran"],"prefix":"10.1177","volume":"22","author":[{"given":"Parvin","family":"Heidarieh","sequence":"first","affiliation":[{"name":"Alborz University of Medical Sciences","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Mirsaeidi","sequence":"additional","affiliation":[{"name":"Miller School of Medicine, University of Miami, Miami"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Hashemzadeh","sequence":"additional","affiliation":[{"name":"Ahvaz Jundishapur University of Medical Sciences","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad Mehdi","family":"Feizabadi","sequence":"additional","affiliation":[{"name":"Tehran University of Medical Sciences","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed Zaker","family":"Bostanabad","sequence":"additional","affiliation":[{"name":"Islamic Azad University Parand Branch","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa Ghalami","family":"Nobar","sequence":"additional","affiliation":[{"name":"Reference Health Laboratory of Iran (RHL)","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abodolrazagh","family":"Hashemi Shahraki","sequence":"additional","affiliation":[{"name":"Pasteur Institute of Iran","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2016,3]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1128\/AAC.48.12.4562-4565.2004","article-title":"Comparative in vitro activities of linezolid, telithromycin, clarithromycin, levofloxacin, moxifloxacin, and four conventional antimycobacterial drugs against Mycobacterium kansasii","volume":"48","author":"Alcaide F.","year":"2004","unstructured":"Alcaide F., , Calatayud L., , Sant\u00edn M., , and Mart\u00edn R. 2004. Comparative in vitro activities of linezolid, telithromycin, clarithromycin, levofloxacin, moxifloxacin, and four conventional antimycobacterial drugs against Mycobacterium kansasii. Antimicrob. Agents Chemother., 48:4562\u20134565.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_3_3_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3855\/jidc.1297","article-title":"Pulmonary disease caused by Mycobacterium simiae in Iran's national referral center for tuberculosis","volume":"6","author":"Baghaei P.","year":"2011","unstructured":"Baghaei P., , Tabarsi P., , Farnia P., , Marjani M., , Sheikholeslami F.M., , Chitsaz M., , Bayani P.G., , Shamaei M., , Mansouri D., , and Masjedi M.R. 2011. Pulmonary disease caused by Mycobacterium simiae in Iran's national referral center for tuberculosis. J. Infect. Dev. Ctries, 6:23\u201328.","journal-title":"J. Infect. Dev. Ctries"},{"key":"e_1_3_3_4_2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/003655498750003528","article-title":"Successful treatment of disseminated Mycobacterium simiae infection in AIDS patients","volume":"30","author":"Barzilai A.","year":"1998","unstructured":"Barzilai A., , Rubinovich B., , Blank-Porat D., , Rubinstein E., , Keller N., , and Levi I. 1998. Successful treatment of disseminated Mycobacterium simiae infection in AIDS patients. Scand. J. Infect. Dis., 30:143\u2013146.","journal-title":"Scand. J. Infect. Dis."},{"key":"e_1_3_3_5_2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1128\/AAC.00861-10","article-title":"Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm (41) and rrl sequencing","volume":"55","author":"Bastian S.","year":"2011","unstructured":"Bastian S., , Veziris N., , Roux A.-L., , Brossier F., , Gaillard J.-L., , Jarlier V., , and Cambau E. 2011. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm (41) and rrl sequencing. Antimicrob. Agents Chemother., 55:775\u2013781.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00059-12"},{"key":"e_1_3_3_7_2","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1086\/338874","article-title":"Mycobacterium simiae infection in an immunocompromised patient without acquired immunodeficiency syndrome","volume":"34","author":"Braun-Saro B.","year":"2002","unstructured":"Braun-Saro B., , Esteban J., , Jim\u00e9nez S., , Castrillo J.M., , Fern\u00e1ndez-Guerrero M.L. 2002. Mycobacterium simiae infection in an immunocompromised patient without acquired immunodeficiency syndrome. Clin. Infect. Dis., 34:e26\u2013e27.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.05030-11"},{"key":"e_1_3_3_9_2","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1128\/JCM.02950-14","article-title":"Utility of sequencing the erm (41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs","volume":"53","author":"Brown-Elliott B.A.","year":"2015","unstructured":"Brown-Elliott B.A., , Vasireddy S., , Vasireddy R., , Iakhiaeva E., , Howard S.T., , Nash K., , Parodi N., , Strong A., , Gee M., , and Smith T. 2015. Utility of sequencing the erm (41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs. J. Clin. Microbiol., 53:1211\u20131215.","journal-title":"J. Clin. Microbiol."},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.15.4.716-746.2002"},{"key":"e_1_3_3_11_2","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/322523","article-title":"Successful treatment of disseminated Mycobacterium chelonae infection with linezolid","volume":"33","author":"Brown-Elliott B.A.","year":"2001","unstructured":"Brown-Elliott B.A., , Wallace R.J., , Blinkhorn R., , Crist C.J., , and Mann L.B. 2001. Successful treatment of disseminated Mycobacterium chelonae infection with linezolid. Clin. Infect. Dis., 33:1433\u20131434.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1085709"},{"key":"e_1_3_3_13_2","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1128\/JCM.00359-07","article-title":"Mycobacterium simiae complex infection in an immunocompetent child","volume":"45","author":"Cruz A.T.","year":"2007","unstructured":"Cruz A.T., , Goytia V.K., , and Starke J.R. 2007. Mycobacterium simiae complex infection in an immunocompetent child. J. Clin. Microbiol., 45:2745\u20132746.","journal-title":"J. Clin. Microbiol."},{"key":"e_1_3_3_14_2","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1099\/jmm.0.45965-0","article-title":"Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates","volume":"54","author":"da Silva Telles M.A.","year":"2005","unstructured":"da Silva Telles M.A., , Chimara E., , Ferrazoli L., , and Riley L.W. 2005. Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates. J. Med. Microbiol., 54:975\u2013979.","journal-title":"J. Med. Microbiol."},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.4103\/0022-3859.65278"},{"key":"e_1_3_3_16_2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0272-5231(02)00016-3","article-title":"Management of disease due to Mycobacterium kansasii","volume":"23","author":"Griffith D.E.","year":"2002","unstructured":"Griffith D.E. 2002. Management of disease due to Mycobacterium kansasii. Clin. Chest Med., 23:613\u2013621.","journal-title":"Clin. Chest Med."},{"key":"e_1_3_3_17_2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/cid\/ciq252","article-title":"The talking Mycobacterium abscessus blues","volume":"52","author":"Griffith D.E.","year":"2011","unstructured":"Griffith D.E. 2011. The talking Mycobacterium abscessus blues. Clin. Infect. Dis., 52:572\u2013574.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200604-571ST"},{"key":"e_1_3_3_19_2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.meegid.2013.08.027","article-title":"Species spectrum of nontuberculous mycobacteria isolated from suspected tuberculosis patients, identification by multi locus sequence analysis","volume":"20","author":"Hashemi-Shahraki A.","year":"2013","unstructured":"Hashemi-Shahraki A., , Bostanabad S.Z., , Heidarieh P., , Titov L.P., , Khosravi A.D., , Sheikhi N., , Ghalami M., , and Nojoumi S.A. 2013. Species spectrum of nontuberculous mycobacteria isolated from suspected tuberculosis patients, identification by multi locus sequence analysis. Infect. Genet. Evol., 20:312\u2013324.","journal-title":"Infect. Genet. Evol."},{"key":"e_1_3_3_20_2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.7883\/yoken.66.475","article-title":"Mycobacterium simiae: a possible emerging pathogen in Iran","volume":"66","author":"Hashemi-Shahraki A.","year":"2013","unstructured":"Hashemi-Shahraki A., , Darban-Sarokhalil D., , Heidarieh P., , Feizabadi M.M., , Deshmir-Salameh S., , Khazaee S., , and Alavi S.M. 2013. Mycobacterium simiae: a possible emerging pathogen in Iran. Jpn. J. Infect. Dis., 66:475\u2013479.","journal-title":"Jpn. J. Infect. Dis."},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/40.1.27"},{"key":"e_1_3_3_22_2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijantimicag.2012.10.021","article-title":"Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan","volume":"41","author":"Huang C.-W.","year":"2013","unstructured":"Huang C.-W., , Chen J.-H., , Hu S.-T., , Huang W.-C., , Lee Y.-C., , Huang C.-C., , and Shen G.-H. 2013. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan. Int. J. Antimicrob. Agents, 41:218\u2013223.","journal-title":"Int. J. Antimicrob. Agents"},{"key":"e_1_3_3_23_2","first-page":"131","article-title":"Pulmonary infection caused by Mycobacteria other than M. tuberculosis in and around Calcutta","volume":"39","author":"Karak K.","year":"1996","unstructured":"Karak K., , Bhattacharyya S., , Majumdar S., , and De P. 1996. Pulmonary infection caused by Mycobacteria other than M. tuberculosis in and around Calcutta. Indian J. Pathol. Microbiol., 39:131.","journal-title":"Indian J. Pathol. Microbiol."},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2014.34.1.31"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit614"},{"key":"e_1_3_3_26_2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.rmed.2010.12.012","article-title":"Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs","volume":"105","author":"Lyu J.","year":"2011","unstructured":"Lyu J., , Jang H.J., , Song J.W., , Choi C.-M., , Oh Y.-M., , Do Lee S., , Kim W.S., , Kim D.S., , and Shim T.S. 2011. Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs. Respir. Med., 105:781\u2013787.","journal-title":"Respir. Med."},{"key":"e_1_3_3_27_2","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1128\/AAC.02448-14","article-title":"Lack of antimicrobial bactericidal activity in Mycobacterium abscessus","volume":"58","author":"Maurer F.P.","year":"2014","unstructured":"Maurer F.P., , Bruderer V.L., , Ritter C., , Castelberg C., , Bloemberg G.V., , and B\u00f6ttger E.C. 2014. Lack of antimicrobial bactericidal activity in Mycobacterium abscessus. Antimicrob. Agents Chemother., 58:3828\u20133836.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh523"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2006.apm_390.x"},{"key":"e_1_3_3_30_2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1183\/09031936.00024008","article-title":"Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease","volume":"33","author":"Santin M.","year":"2009","unstructured":"Santin M., , Dorca J., , Alcaide F., , Gonzalez L., , Casas S., , Lopez M., , and Guerra M. 2009. Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease. Eur. Respir. J., 33:148\u2013152.","journal-title":"Eur. Respir. J."},{"key":"e_1_3_3_31_2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejim.2015.03.001","article-title":"\u201cMultidrug-resistant tuberculosis\u201d. may be nontuberculous mycobacteria","volume":"26","author":"Shahraki A.H.","year":"2015","unstructured":"Shahraki A.H., , Heidarieh P., , Bostanabad S.Z., , Khosravi A.D., , Hashemzadeh M., , Khandan S., , Biranvand M., , Schraufnagel D.E., , and Mirsaeidi M. 2015. \u201cMultidrug-resistant tuberculosis\u201d. may be nontuberculous mycobacteria. Eur. J. Intern. Med., 26:279\u2013284.","journal-title":"Eur. J. Intern. Med."},{"key":"e_1_3_3_32_2","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/AAC.01551-06","article-title":"In vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan","volume":"51","author":"Shen G.-H.","year":"2007","unstructured":"Shen G.-H., , Wu B.-D., , Wu K.-M., , and Chen J.-H. 2007. In vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan. Antimicrob. Agents Chemother., 51:1849\u20131851.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.7883\/yoken.64.265"},{"key":"e_1_3_3_34_2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MAJ.0b013e318185d32f","article-title":"Nontuberculous mycobacteria among patients who are suspected for multidrug-resistant tuberculosis-need for earlier identification of nontuberculosis mycobacteria","volume":"337","author":"Tabarsi P.","year":"2009","unstructured":"Tabarsi P., , Baghaei P., , Farnia P., , Mansouri N., , Chitsaz E., , Sheikholeslam F., , Marjani M., , Rouhani N., , Mirsaeidi M., , and Alipanah N. 2009. Nontuberculous mycobacteria among patients who are suspected for multidrug-resistant tuberculosis-need for earlier identification of nontuberculosis mycobacteria. Am. J. Med. Sci., 337:182\u2013184.","journal-title":"Am. J. Med. Sci."},{"key":"e_1_3_3_35_2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1183\/09031936.00076107","article-title":"Clinical relevance of Mycobacterium simiae in pulmonary samples","volume":"31","author":"van Ingen J.","year":"2008","unstructured":"van Ingen J., , Boeree M., , Dekhuijzen P., , and Van Soolingen D. 2008. Clinical relevance of Mycobacterium simiae in pulmonary samples. Eur. Respir. J., 31:106\u2013109.","journal-title":"Eur. Respir. J."},{"key":"e_1_3_3_36_2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijantimicag.2011.09.019","article-title":"Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease","volume":"39","author":"van Ingen J.","year":"2012","unstructured":"van Ingen J., , Totten S.E., , Heifets L.B., , Boeree M.J., , and Daley C.L.. 2012. Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease. Int. J. Antimicrob. Agents, 39:173\u2013176.","journal-title":"Int. J. Antimicrob. Agents"},{"key":"e_1_3_3_37_2","doi-asserted-by":"crossref","first-page":"e114428","DOI":"10.1371\/journal.pone.0114428","article-title":"Molecular epidemiology of nontuberculous mycobacteria isolates from clinical and environmental sources of a metropolitan city","volume":"9","author":"Velayati A.A.","year":"2014","unstructured":"Velayati A.A., , Farnia P., , Mozafari M., , Malekshahian D., , Seif S., , Rahideh S., , and Mirsaeidi M. 2014. Molecular epidemiology of nontuberculous mycobacteria isolates from clinical and environmental sources of a metropolitan city. PLoS One, 9:e114428.","journal-title":"PLoS One"},{"key":"e_1_3_3_38_2","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/AAC.45.3.764-767.2001","article-title":"Activities of linezolid against rapidly growing mycobacteria","volume":"45","author":"Wallace R.","year":"2001","unstructured":"Wallace R., , Brown-Elliott B., , Ward S., , Crist C., , Mann L., , and Wilson R. 2001. Activities of linezolid against rapidly growing mycobacteria. Antimicrob. Agents Chemother., 45:764\u2013767.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/15.1.1"},{"key":"e_1_3_3_40_2","volume-title":"Approved standard","author":"Woods G.L.","year":"2003","unstructured":"Woods G.L., , Brown-Elliott B., , Desmond E.P., , Hall G.S., , Heifets L., , Pfyffer G.E., , Ridderhof J.C., , Wallace R.J.Jr., , Warren N.G., , and Witebsky F.G. 2003. Susceptibility testing of Mycobacteria, Nocardia, and other Actinomycetes. In Approved standard M24-A, vol. 23, no. 18. NCCLS, Wayne, PA."},{"key":"e_1_3_3_41_2","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jac\/dkp238","article-title":"Clinical manifestations, antibiotic susceptibility and molecular analysis of Mycobacterium kansasii isolates from a university hospital in Taiwan","volume":"64","author":"Wu T.-S.","year":"2009","unstructured":"Wu T.-S., , Leu H.-S., , Chiu C.-H., , Lee M.-H., , Chiang P.-C., , Wu T.-L., , Chia J.-H., , Su L.-H., , Kuo A.-J., , and Lai H.-C. 2009. Clinical manifestations, antibiotic susceptibility and molecular analysis of Mycobacterium kansasii isolates from a university hospital in Taiwan. J. Antimicrob. Chemother., 64:511\u2013514.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_3_42_2","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1128\/AAC.47.6.1958-1962.2003","article-title":"High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan","volume":"47","author":"Yang S.-C.","year":"2003","unstructured":"Yang S.-C., , Hsueh P.-R., , Lai H.-C., , Teng L.-J., , Huang L.-M., , Chen J.-M., , Wang S.-K., , Shie D.-C., , Ho S.-W., , and Luh K.-T. 2003. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan. Antimicrob. Agents Chemother., 47:1958\u20131962.","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Microbial Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mdr.2015.0134","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2015.0134","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2015.0134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:29:34Z","timestamp":1777667374000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/mdr.2015.0134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.1089\/mdr.2015.0134"],"URL":"https:\/\/doi.org\/10.1089\/mdr.2015.0134","relation":{},"ISSN":["1076-6294","1931-8448"],"issn-type":[{"value":"1076-6294","type":"print"},{"value":"1931-8448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}